Additionally, a recent review highlighted the prognostic value of various serological markers in IIM-ILD, including chitinase-3-like protein 1 (YKL-40) and a range of myositis-specific autoantibodies such as anti-aminoacyl-tRNA synthetase and anti-MDA5 [56]. This evidence concerns the gene CHI3L1 and interstitial lung disease.